Autism Spectrum Disorders
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
We also found a novel ASD-associated deletion of PTCHD1-AS exon 3 and showed that exon 3 loss altered PTCHD1-AS splicing without affecting expression of the neighboring PTCHD1 coding gene.
|
31540669 |
2020 |
Autism Spectrum Disorders
|
0.400 |
Biomarker
|
disease |
BEFREE |
We next determined possible involvement of the kynurenine pathway (KP) metabolites in neurodevelopmental disorders in Ptchd1 KO mice and assessed the potential of KP metabolites as biomarkers for ADHD and/or ASD.
|
31515500 |
2019 |
Autism Spectrum Disorders
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Deleterious mutations in the PTCHD1 (Patched domain containing 1) gene have been described in male patients with X-linked ID and/or ASD.
|
28416808 |
2018 |
Autism Spectrum Disorders
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Recently, gene mutations in patched domain containing 1 (PTCHD1) have been found in ~1% of patients with ID and ASD.
|
27007844 |
2016 |
Autism Spectrum Disorders
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Phenotypic spectrum associated with PTCHD1 deletions and truncating mutations includes intellectual disability and autism spectrum disorder.
|
25131214 |
2015 |
Autism Spectrum Disorders
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
No rare missense PTCHD1 variants were found in our ASD cohort and only one was identified in the ID sample.
|
25782667 |
2015 |
Autism Spectrum Disorders
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
This strategy has proven largely successful in identifying ASD-susceptibility candidate loci, including gains and losses at 16p11.2, SHANK2, NRXN1, and PTCHD1.
|
22228009 |
2012 |
Autism Spectrum Disorders
|
0.400 |
Biomarker
|
disease |
BEFREE |
This finding seemed interesting, given recent discoveries on the role of another Patched-domain containing gene (PTCHD1) in ASD.
|
21439084 |
2011 |
Autism Spectrum Disorders
|
0.400 |
Biomarker
|
disease |
CTD_human |
Thus, our systematic screen of PTCHD1 and its 5' flanking regions suggests that this locus is involved in ~1% of individuals with ASD and intellectual disability.
|
20844286 |
2010 |
Autism Spectrum Disorders
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Thus, our systematic screen of PTCHD1 and its 5' flanking regions suggests that this locus is involved in ~1% of individuals with ASD and intellectual disability.
|
20844286 |
2010 |
Autism Spectrum Disorders
|
0.400 |
Biomarker
|
disease |
CTD_human |
Notwithstanding complexities, our results further implicate the SHANK3-NLGN4-NRXN1 postsynaptic density genes and also identify novel loci at DPP6-DPP10-PCDH9 (synapse complex), ANKRD11, DPYD, PTCHD1, 15q24, among others, for a role in ASD susceptibility.
|
18252227 |
2008 |
Autism Spectrum Disorders
|
0.400 |
Biomarker
|
disease |
BEFREE |
Notwithstanding complexities, our results further implicate the SHANK3-NLGN4-NRXN1 postsynaptic density genes and also identify novel loci at DPP6-DPP10-PCDH9 (synapse complex), ANKRD11, DPYD, PTCHD1, 15q24, among others, for a role in ASD susceptibility.
|
18252227 |
2008 |